Michael Stark: How Glucocorticoids in Pregnancy Affect Fetal Development and Why It Matters
Michael Stark, Professor of Neonatal Medicine and Deputy Director of Clinical Research at the Robinson Research Institute, Director of Neonatal Medicine at the University of Adelaide and Head of Neonatal Services at the Women’s and Children’s Hospital Adelaide, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Endocrine Reviews, adding:
“Our latest article about the critical role of glucocorticoids in pregnancy and the importance of understanding the underlying mechanisms of how they effect the fetus.
A significant step towards identifying ‘responsive subgroups‘ to optimise antenatal steroid therapy and move away from a simplistic one-size-fits-all approach to management of preterm birth.”
Title: Glucocorticoids in pregnancy: A master-switch for fetal maturation
Authors: Yoshi Tan, Michael J Stark, Vicki L Clifton, Michael D Wiese, Janna L Morrison, Kathryn L Gatford
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026
-
Jul 13, 2026, 10:02Jessica Garcia: Where Science and Community Come Together at ISTH 2026
-
Jul 13, 2026, 09:46Fabrice Cognasse: Is There Such a Thing as the Perfect Platelet Product?
-
Jul 13, 2026, 09:42Cancer-Associated Arterial Thromboembolism: Redefining the Thrombotic Burden in Oncology
-
Jul 13, 2026, 05:59Connecting and Collaborating at ISTH 2026 – NNHF
-
Jul 13, 2026, 05:58Lara Monica: Back at ISTH – Looking Forward to Science and Reconnections!
-
Jul 13, 2026, 05:57Barbara Adams Krolak: Exciting Updates From the ISTH 2026 Regulatory Session